ZA918965B - Nucleic acid amplification by two-enzyme,self-sustained sequence replication - Google Patents

Nucleic acid amplification by two-enzyme,self-sustained sequence replication

Info

Publication number
ZA918965B
ZA918965B ZA918965A ZA918965A ZA918965B ZA 918965 B ZA918965 B ZA 918965B ZA 918965 A ZA918965 A ZA 918965A ZA 918965 A ZA918965 A ZA 918965A ZA 918965 B ZA918965 B ZA 918965B
Authority
ZA
South Africa
Prior art keywords
enzyme
self
nucleic acid
acid amplification
sequence replication
Prior art date
Application number
ZA918965A
Inventor
Eoin David Fahy
David Fahy Eoin
Deborah Yantis Kwoh
Yantis Kwoh Deborah
Thomas Raymond Gingeras
Raymond Gingeras Thomas
John Christopher Guatelli
Christopher Guatelli John
Kristina Marie Whitefield
Marie Whitefield Kristina
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of ZA918965B publication Critical patent/ZA918965B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA918965A 1990-11-13 1991-11-12 Nucleic acid amplification by two-enzyme,self-sustained sequence replication ZA918965B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13

Publications (1)

Publication Number Publication Date
ZA918965B true ZA918965B (en) 1992-08-26

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918965A ZA918965B (en) 1990-11-13 1991-11-12 Nucleic acid amplification by two-enzyme,self-sustained sequence replication

Country Status (13)

Country Link
EP (1) EP0572417A4 (en)
JP (1) JPH06502767A (en)
AU (1) AU9131591A (en)
CA (1) CA2096013A1 (en)
FI (1) FI932144A0 (en)
HU (1) HUT69772A (en)
IE (1) IE913930A1 (en)
IL (1) IL100040A (en)
NO (1) NO931709L (en)
NZ (1) NZ240574A (en)
PT (1) PT99500A (en)
WO (1) WO1992008800A1 (en)
ZA (1) ZA918965B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628076A1 (en) * 1992-11-19 1994-12-14 GINGERAS, Thomas R. PRODUCTION OF MONOCLONAL RECOMBINANT ANTIBODIES WITHOUT THE USE OF HYBRIDOMAS BY $i(IN VITRO) SPLEEN FRAGMENT CULTURE COMBINED WITH ISOTHERMAL SELF-SUSTAINED SEQUENCE REPLICATION OF RNA
EP0682121B1 (en) * 1993-12-01 2002-08-28 Toyo Boseki Kabushiki Kaisha Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (en) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd Reverse transcriptase-stabilized composition
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (en) * 1999-07-16 2001-02-06 Shimadzu Corp Amplification of rna
US7238795B2 (en) 2000-08-03 2007-07-03 Roche Molecular Systems, Inc. Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
US6780588B2 (en) * 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
DE60316660T3 (en) 2002-01-08 2016-01-28 Roche Diagnostics Gmbh USE OF A SILICA MATERIAL IN AMPLIFICATION
US7122314B2 (en) 2002-01-30 2006-10-17 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (en) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Improved procedures for the synthesis of nucleic acids
ES2294462T5 (en) 2003-01-29 2015-05-06 Epigenomics Ag Improved method for bisulfite treatment
JP2004357502A (en) * 2003-05-30 2004-12-24 Olympus Corp Method for processing information using nucleic acid molecule
WO2006006722A1 (en) 2004-07-13 2006-01-19 Takeda Pharmaceutical Company Limited Method of controlling cell functions
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2185726B1 (en) 2007-08-06 2014-01-08 Orion Genomics, LLC Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
EP2851432B1 (en) 2007-11-01 2019-01-09 University of Iowa Research Foundation RCA locus analysis to assess susceptibility to AMD
EP2396429B1 (en) 2009-02-11 2015-05-27 Orion Genomics, LLC Combinations of polymorphisms for determining allele-specific expression of igf2
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
WO2011153254A2 (en) 2010-06-04 2011-12-08 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US20140004510A1 (en) 2010-09-24 2014-01-02 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
WO2012054727A1 (en) 2010-10-22 2012-04-26 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
MX2014002311A (en) 2011-08-31 2014-08-26 Hoffmann La Roche Responsiveness to angiogenesis inhibitors.
MX2014002307A (en) 2011-08-31 2014-08-26 Hoffmann La Roche Method for predicting risk of hypertension associated with anti-angiogenesis therapy.
CA2846630A1 (en) 2011-09-19 2013-03-28 Genentech, Inc. Combination treatments comprising c-met antagonists and b-raf antagonists
CA2852098C (en) 2011-10-21 2023-05-02 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
WO2013076029A1 (en) 2011-11-23 2013-05-30 F. Hoffmann-La Roche Ag Responsiveness to angiogenesis inhibitors
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
EP3004388B2 (en) 2013-05-29 2023-05-31 Chronix Biomedical Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
EP3572093A1 (en) 2014-03-31 2019-11-27 Debiopharm International SA Fgfr fusions
EP3218515B1 (en) 2014-11-10 2023-04-26 F. Hoffmann-La Roche AG Therapeutic and diagnostic methods for il-33-mediated disorders
AU2016252998B2 (en) 2015-04-24 2021-11-04 Atila Biosystems Incorporated Amplification with primers of limited nucleotide composition
KR101885361B1 (en) 2015-08-17 2018-08-06 쿠라 온콜로지, 인크. How to treat cancer patients using parnesyl transferase inhibitor
WO2017184968A1 (en) 2016-04-22 2017-10-26 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
JP2019534290A (en) 2016-11-03 2019-11-28 クラ オンコロジー， インコーポレイテッド Farnesyltransferase inhibitors for use in methods of treating cancer
US9956215B1 (en) 2017-02-21 2018-05-01 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
TWI693074B (en) 2017-02-21 2020-05-11 美商庫拉腫瘤技術股份有限公司 Methods of treating cancer with farnesyltransferase inhibitors
BR112020002591A2 (en) 2017-08-07 2020-07-28 Kura Oncology, Inc. method for treating cancer
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2019218128A1 (en) 2018-02-09 2020-09-17 Genentech, Inc. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
AU2019372141A1 (en) 2018-11-01 2021-05-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220142983A1 (en) 2019-03-01 2022-05-12 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CA3134825A1 (en) 2019-03-29 2020-10-08 Kura Oncology, Inc. Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
WO2020205387A1 (en) 2019-04-01 2020-10-08 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220305001A1 (en) 2019-05-02 2022-09-29 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
WO2021180858A1 (en) 2020-03-13 2021-09-16 Medimmune Limited Therapeutic methods for the treatment of subjects with risk alelles in il33
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
ZA899593B (en) * 1988-12-16 1990-09-26 Siska Diagnostics Inc Self-sustained,sequence replication system
DE69028257T2 (en) * 1989-07-11 1997-01-09 Gen Probe Inc Process for the amplification of nucleic acid sequences

Also Published As

Publication number Publication date
FI932144A (en) 1993-05-12
NO931709D0 (en) 1993-05-11
WO1992008800A1 (en) 1992-05-29
EP0572417A1 (en) 1993-12-08
HUT69772A (en) 1995-09-28
NZ240574A (en) 1994-10-26
FI932144A0 (en) 1993-05-12
IL100040A (en) 1995-12-31
NO931709L (en) 1993-07-12
EP0572417A4 (en) 1994-11-23
HU9301369D0 (en) 1993-10-28
AU9131591A (en) 1992-06-11
IE913930A1 (en) 1992-06-17
JPH06502767A (en) 1994-03-31
IL100040A0 (en) 1992-08-18
PT99500A (en) 1992-10-30
CA2096013A1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
IL100040A0 (en) Nucleic acid amplification by two-enzyme,self-sustained sequence replication
NZ241311A (en) Rna sequence having trans-splicing activity, plant strains
NO875411D0 (en) COMPOSITION MATERIALS, SPECIAL FOR TURBIN SHEETS.
IL85961A (en) Leukemia-inhibitory factor, its purification and production, dna which encodes it, cells transformed by said dna and pharmaceutical compositions containing said factor
EP0262463A3 (en) Novel aureobasidium sp. microorganisms, method for preparing erythritol with the same
DE3680137D1 (en) PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND INSECTICIDES, ACARICIDES, NEMATICIDES, FUNGICIDAL COMPOSITIONS.
GB9009307D0 (en) Dna,constructs,cells and plant derived therefrom
NO885280D0 (en) DIGITAL, PHASE-DOWN SLFEKRETS WITH H OPPLNING.
DE3880984D1 (en) EMULSION-EXPLOSIVE, EMULSIFIER.
AU8597791A (en) 3-alkoxyalkanoic acid derivative, process for preparing the same and herbicide using the same
FI880454A0 (en) LAOSANORDNING, SAERSKILT FOER EN LUCKA TILL EN DAMMSUGARE.
EG18865A (en) Phenoxypenythioureas, phenoxyphenylisothiourreas and phenoxyphenylcarbodiimides and use thereof for controlling pests.
AU8419191A (en) Dna, dna constructs, cells and plants derived therefrom
DE69204806D1 (en) 1-cyanomethyl-4-carboxymethyl-3-ketopiperazines, their salts and process for their preparation.
IL56822A0 (en) Pentafluorobanzyloxycarbonyl derivatives,their preparationand their use as insecticides and acaricides
DE3574706D1 (en) CHARTREUSIN DERIVATIVES, THEIR SALTS, ANTITUMORAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF.
DE3887281D1 (en) 1,2,3,4-tetrahydro-5-nitro-pyrimidine derivatives.
NL193406B (en) Fertilizer with high hardness and storage stability, as well as its preparation.
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
AU8641391A (en) Dna, dna constructs, cells and plants derived therefrom
GR1002048B (en) Phenilacetic acid derivatives, process for the preparation thereof and corresponding use.
NO880088D0 (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives.
FI893184A (en) BEHAOLLARE FOER TRANSPORT AV LAONGSTRAECKTA FOEREMAOL, I SYNNERHET VALSAR TILL PAPPERSMASKINER.
EP0264748A3 (en) Cell culture medium made from cohn supernatant fraction v
Bruchal Innovations, strategies for implementation